Acclivity Technologies is a discovery to preclinical health technologies company based in North Carolina.
We are assessing the measurability of ATI-0019, a novel small molecule capable of modulating endothelial cell activity, for use as a biomarker in research, consumer health, wellness and aging applications and clinical diagnostics, as well as assessing the pharmacological properties of ATI-0019 and developing a library of related compounds for therapeutic use in aging related cardiovascular and other diseases. Future investigations will explore potential drug/device combinations, smart devices, and diagnostic applications.
Rooted in the realms of biochemistry and endothelial cell biology, and fortified by years of experience in R&D leadership and product development, ATI is driven by the collective expertise of its founders. With a vision that transcends conventional boundaries, we are poised to redefine consumer health, wellness, and aging solutions through pioneering research and strategic leadership. Our founders' profound understanding of biochemical intricacies and endothelial cell dynamics forms the cornerstone of our approach. Strategic foresight and unwavering commitment to excellence propel us toward groundbreaking advancements, as we strive to address unmet medical needs with precision and dedication. Guided by our vision, ATI stands at the forefront of innovation, poised to empower individuals worldwide to take control of their health, embrace vitality, and thrive at every stage of life.
Features of ATI’s integrated product development approach include:
By integrating biomarker development into its consumer health, wellness, and aging initiatives, ATI will offer innovative solutions that empower individuals to proactively manage their health, detect age-related diseases at an early stage, and receive personalized treatment interventions tailored to their unique biomarker profiles.
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.